Skip to the page

Data / Form D filings / Vesalius Longevity Labs (Canada) Inc.

Vesalius Longevity Labs (Canada) Inc.: Form D filing

Vesalius Longevity Labs (Canada) Inc., a company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2025. The latest, on June 30, 2025, reports $168,000 sold of a $168,000 offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1500 - 1055 WEST GEORGIA STREET, Vancouver, British Columbia, Canada, V6E 4
Phone
(604) 687-7130
Industry
Other
Entity type
Corporation
Incorporated in
British Columbia, Canada
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2074113

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 30, 2025New notice$168,000$168,0006May 23, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
JOEL LEONOFFDirector
RICHARD SERBINDirector
SHANNON ANDERSONExecutive Officer, Director
TIMMOTHY EVE STUMPExecutive Officer
MARK PATRICOFDirector
KEVIN RABBITTExecutive Officer, Director
C. FRANK I. DUNSFORDExecutive Officer
SHANNON FRANK I. LOUDENExecutive Officer
JASON FRANK I. SUSLAKExecutive Officer

Every Form D from the week of Jun 30, 2025 · All recent Other filings

Read from SEC EDGAR. Amount sold is what Vesalius Longevity Labs (Canada) Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.